- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Next Generation Cryo Sample Prep Tool Offers New Levels of Automation and Ease of Use
has introduced the next generation of its popular Vitrobot™ cryo sample preparation tool, the Vitrobot Mark IV. The Mark IV is an easy-to-use system that features a newly-designed touchscreen user interface operated under a Linux operating system and robotics that ensures high-quality, reproducible freezing of samples. Automated transfer from the vitrification medium into the liquid nitrogen atmosphere offers more consistent and higher yield sample throughput.
Three-dimensional transmission electron microscopy (TEM) visualization of macromolecular structures and molecular machines in their native hydrated state has become a critical tool for structural biologists focusing on interactive biological and biochemical processes at the macromolecular level. The Vitrobot is a high-throughput tool designed to enable the physical fixation of biological structures within ultra-thin vitrified ice layers so samples can withstand the high voltages used in TEMs long enough to acquire the necessary image.
Beyond biological applications, the Vitrobot Mark IV can also be used for pharmaceutical, food and a variety of general industrial applications where colloidal structures need to be characterized and analyzed.
FEI will feature the Vitrobot Mark IV at the 26th Annual Meeting of the American Society for Virology, July 15-17, 2007 at Oregon State University in Corvallis, Ore. and at the Microscopy and Microanalysis meeting August 6-9, 2007 in Fort Lauderdale, Fla. (Booth 414). More about the Vitrobot can be discovered at http://www.fei.com/vitrobot .
About FEI Company
FEI (Nasdaq: FEIC) is a global leader in providing innovative instruments for nanoscale imaging, analysis and prototyping. FEI focuses on delivering solutions that provide groundbreaking results and accelerate research, development and manufacturing cycles for its customers in Semiconductor and Data Storage, Academic and Industrial R&D, and Life Sciences markets. With R&D centers in North America and Europe, and sales and service operations in more than 50 countries around the world, FEI’s Tools for Nanotech™ are bringing the nanoscale within the grasp of leading researchers and manufacturers. More information can be found online at http://www.fei.com .
This news release contains forward-looking statements about a new cryo sample preparation product and its capabilities. Factors that could affect these forward-looking statements include but are not limited to delays in the roll-out of the product, manufacturing or delivery delays, failure of suppliers to deliver products on time and to specification, and failure of the product to perform as expected due to technical or other reasons. Please also refer to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on these factors and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update forward-looking statements.
For more information, please click here
Dan Zenka, APR
Global Public Relations
+1 503 726 2695
Copyright © FEI CompanyIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Radiation-guided nanoparticles zero in on metastatic cancer July 1st, 2016
FEI Launches Helios G4 DualBeam Series for Materials Science: The Helios G4 DualBeam Series features new capabilities to enable scientists and engineers to answer the most demanding and challenging scientific questions June 27th, 2016
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Novel gene therapy shows potential for lung repair in asthma May 18th, 2016